Sigma Pharmaceutical
Supervised by: Dr. Ashraf Sheta
Prepared by: Wael Atef Taha
ESLSCA 37 D
Oct, 2012
Table of Content :
Part I : Strategic posture 1. Organizational profile | | | 5 | 2. Vision | | | 6 | 3. Mission | | | 6 | 4. Organizational objectives | | | 7 | 5. Corporate governance | | | 8 | 6. CSR | | | 9 | 7. Core values | | | 10 | 8. Code of conduct | | | 10 |
Part II : External factor analysis 9. Stakeholders analysis | | | 11 | 10. PESTEL analysis | | | 13 | 11. Task environment | | | 14 | 12. Issues priority matrix | | | 15 | 13. Porter five competitive forces analysis | | | 16 | 14. Strategic group | | | 17 | 15. Strategic type | | | 17 | 16. Industry matrix | | | 18 | 17. EFAS | | | 19 |
Part III : Internal factor analysis 18. Core competence | | | 21 | 19. Core products | | | 21 | 20. End products | | | 22 | 21. Competitive advantage | | | 22 | 22. Business model | | | 25 | 23. Industry value chain | | | 26 | 24. Value chain analysis | | | 27 | 25. Organizational structure | | | 29 | 26. Cultural analysis | | | 30 | 27. Departmental or business unit issues | | 27 | |
Part III : Internal factor analysis 28. IFAS | | | 31 | 29. SWOT | | | 32 | 30. SFAS | | | 33 |
Part IV : Strategy Formula 31. TOWS | | | 35 | 32. Business Competitive Strategy | | | 37 | 33. Cooperative Strategy | | | 38 | 34. Corporate Strategy | | | 38 | 35. BGG Matrix | | | 39 | 36. Functional Strategy | | | 40 |
Part V : Strategy Implementation 37. Implementation Program | | | 42 | 38. KPI’s on Corporate | | | 45 | 39. Performance Evaluation | | | 46 | 40.